These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
67 related articles for article (PubMed ID: 3148569)
1. [The association between mortality and the cost of medications persists even controlling for per capita income]. Porta Serra M; Kritchevsky SB Gac Sanit; 1987; 1(1):5-11. PubMed ID: 3148569 [No Abstract] [Full Text] [Related]
2. [Needs of cost-effectivity analysis for the optimization and rationalization of expense in new drugs]. Soto Alvarez J Med Clin (Barc); 2008 Apr; 130(14):559. PubMed ID: 18457627 [No Abstract] [Full Text] [Related]
4. ILO looks at possible methods of controlling world-wide social security health care costs. Employee Benefit Plan Rev; 1977 May; 31(11):46-7. PubMed ID: 10304791 [No Abstract] [Full Text] [Related]
6. Containing the rising cost of medical care under social security. WHO Chron; 1977 Oct; 31(10):408-12. PubMed ID: 412326 [No Abstract] [Full Text] [Related]
7. Drug-related morbidity and mortality: an economic and clinical perspective. Bootman JL Manag Care; 2002 Feb; 11(2 Suppl):12-5. PubMed ID: 11907995 [No Abstract] [Full Text] [Related]
8. Cost-effective outlays for better health outcomes. Shmueli A World Health Forum; 1995; 16(3):287-92. PubMed ID: 7546177 [TBL] [Abstract][Full Text] [Related]
9. [Social and health care factors and perinatal mortality in Spain--ecological study]. Salleras L; Sentis J; Canela J; Garcia A Rev Epidemiol Sante Publique; 1988; 36(1):30-5. PubMed ID: 3368607 [TBL] [Abstract][Full Text] [Related]
10. Effect of SSI on Medicaid caseloads and expenditures. Hawkins SC; Rigby DE Soc Secur Bull; 1979 Feb; 42(2):3-14. PubMed ID: 108807 [TBL] [Abstract][Full Text] [Related]
11. Do factors other than need determine utilization of physicians' services in Ontario? Finkelstein MM CMAJ; 2001 Sep; 165(5):565-70. PubMed ID: 11563208 [TBL] [Abstract][Full Text] [Related]
12. Income distribution, public services expenditures, and all cause mortality in US States. Dunn JR; Burgess B; Ross NA J Epidemiol Community Health; 2005 Sep; 59(9):768-74. PubMed ID: 16100315 [TBL] [Abstract][Full Text] [Related]
13. How pharmaceuticals cut direct & indirect costs of therapy. Levy RA Pharm Times; 1985 Dec; 51(12):82-8. PubMed ID: 10311420 [No Abstract] [Full Text] [Related]
14. The economic burden of prescription drug use among elderly patients in Ponce, Puerto Rico. López-Negrón L; Monsanto-Planadeball HA P R Health Sci J; 2006 Jun; 25(2):149-53. PubMed ID: 17203713 [TBL] [Abstract][Full Text] [Related]
15. Public social welfare expenditures, fiscal year 1984. Bixby AK Soc Secur Bull; 1987 Jun; 50(6):21-32. PubMed ID: 3114897 [No Abstract] [Full Text] [Related]
16. The relevance of unrelated costs internal and external to the healthcare sector to the outcome of a cost-comparison analysis of secondary prevention: the case of general colorectal cancer screening in the German population. Tscheulin DK; Drevs F Eur J Health Econ; 2010 Apr; 11(2):141-50. PubMed ID: 19449159 [TBL] [Abstract][Full Text] [Related]
17. Controlling prescription drug expenditures: a report of success. Miller DP; Furberg CD; Small RH; Millman FM; Ambrosius WT; Harshbarger JS; Ohl CA Am J Manag Care; 2007 Aug; 13(8):473-80. PubMed ID: 17685828 [TBL] [Abstract][Full Text] [Related]
18. Patient compliance: changing patterns of disease and health care costs. Cluff LE Hosp Formul; 1985 Apr; 20(4):503-4, 507, 510. PubMed ID: 10311084 [TBL] [Abstract][Full Text] [Related]
19. Focus on drugs. Vail S Can Nurse; 1996 Jan; 92(1):60, 59. PubMed ID: 8920559 [TBL] [Abstract][Full Text] [Related]
20. The development of a value based pricing index for new drugs in metastatic colorectal cancer. Dranitsaris G; Truter I; Lubbe MS Eur J Cancer; 2011 Jun; 47(9):1299-304. PubMed ID: 21493060 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]